Corporate roadshows pile up as ECB keeps lid on spreads
A steady flow of deals is running through the investment grade corporate bond pipeline and out into the market. This is expected to become a deluge before long, as investors’ inboxes are filling up with roadshow invitations.
German pharmaceutical company Bayer is the latest to join the queue, having announced a mandate for a dual tranche euro hybrid capital issue on Wednesday with maturities of 60 non-call 5.5 years and non-call eight (see separate story).
“It was expected,” said an investor, “but it’s still ...Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Or sign up for a trial to gain full access to the entire site for a limited period.
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.
